- Home
- BANC vs HRMY Comparison
BANC vs HRMY Comparison
Compare BANC & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANC
- HRMY
- Stock Information
- Founded
- BANC 1941
- HRMY 2017
- Country
- BANC United States
- HRMY United States
- Employees
- BANC N/A
- HRMY N/A
- Industry
- BANC Major Banks
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- BANC Finance
- HRMY Health Care
- Exchange
- BANC Nasdaq
- HRMY Nasdaq
- Market Cap
- BANC 2.2B
- HRMY 1.8B
- IPO Year
- BANC N/A
- HRMY 2020
- Fundamental
- Price
- BANC $14.97
- HRMY $34.00
- Analyst Decision
- BANC Buy
- HRMY Strong Buy
- Analyst Count
- BANC 11
- HRMY 9
- Target Price
- BANC $17.18
- HRMY $54.44
- AVG Volume (30 Days)
- BANC 2.2M
- HRMY 642.5K
- Earning Date
- BANC 07-23-2025
- HRMY 08-05-2025
- Dividend Yield
- BANC 2.67%
- HRMY N/A
- EPS Growth
- BANC N/A
- HRMY 13.13
- EPS
- BANC 0.65
- HRMY 2.62
- Revenue
- BANC $964,190,000.00
- HRMY $744,852,000.00
- Revenue This Year
- BANC $8.39
- HRMY $20.10
- Revenue Next Year
- BANC $10.47
- HRMY $18.01
- P/E Ratio
- BANC $23.03
- HRMY $13.10
- Revenue Growth
- BANC 415.34
- HRMY 20.62
- 52 Week Low
- BANC $11.52
- HRMY $26.47
- 52 Week High
- BANC $18.08
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- BANC 65.02
- HRMY 58.91
- Support Level
- BANC $14.53
- HRMY $31.70
- Resistance Level
- BANC $15.34
- HRMY $35.08
- Average True Range (ATR)
- BANC 0.34
- HRMY 0.95
- MACD
- BANC 0.10
- HRMY 0.27
- Stochastic Oscillator
- BANC 78.81
- HRMY 71.80
About BANC Banc of California Inc.
Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.